scispace - formally typeset
C

Chia-Ing Li

Researcher at China Medical University (Taiwan)

Publications -  233
Citations -  640

Chia-Ing Li is an academic researcher from China Medical University (Taiwan). The author has contributed to research in topics: Medicine & China. The author has an hindex of 10, co-authored 233 publications receiving 474 citations. Previous affiliations of Chia-Ing Li include China Medical University (PRC).

Papers
More filters
Journal ArticleDOI

Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan

TL;DR: This study investigated whether diabetes mellitus (DM) increased the risk of pancreatic cancer and whether anti‐diabetic drugs reduced the risk in Taiwan and found no difference between the two.
Journal ArticleDOI

Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study

TL;DR: The risk factors for cholelithiasis were obesity, hyperlipidemia, hepatitis B infection, hepatitis C infection, and cirrhosis in both genders, and menopause in females, and no unique risk factors were identified among the population of Taiwan.
Journal ArticleDOI

Microalbuminuria and the metabolic syndrome and its components in the Chinese population.

TL;DR: This study investigated the association between urinary albumin‐to‐creatinine ratio (ACR) and MetS and its components and found no significant association between the two.
Journal ArticleDOI

In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study)

TL;DR: This study examined the relationship between hyperuricemia and metabolic syndrome using five different definitions (proposed by the World Health Organization, the National Cholesterol Education Program Third Adult Treatment Panel, the modified NCEP-ATPIII, the International Diabetes Federation, and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) in Taiwan.
Journal ArticleDOI

Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial.

TL;DR: The pharmacist-physician collaborative MTM program for polypharmacy elderly had significant cost savings and improvement in humanistic measures, demonstrating the importance of clinical pharmacists and MTM programs for elderly patients in Taiwan.